Ocular toxoplasmosis: new directions for clinical investigation.
Holland
G N
GN
UCLA Ocular Inflammatory Disease Center, Jules Stein Institute, Los Angeles, CA 90095-7003, USA.
D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D056890:Eukaryota; D005544:Forecasting; D006801:Humans; D012698:Serologic Tests; D014126:Toxoplasmosis, Ocular / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology*
D000981:Antiprotozoal Agents